Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
- PMID: 31959092
- DOI: 10.1177/1010428319901052
Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer
Abstract
Feline invasive mammary carcinomas are characterized by their high clinical aggressiveness, rare expression of hormone receptors, and pathological resemblance to human breast cancer, especially triple-negative breast cancer (negative to estrogen receptor, progesterone receptor, and epidermal growth factor receptor type 2). Recent gene expression studies of triple-negative breast cancers have highlighted their heterogeneity and the importance of immune responses in their biology and prognostic assessment. Indeed, regulatory T cells may play a crucial role in producing an immune-suppressed microenvironment, notably in triple-negative breast cancers. Feline invasive mammary carcinomas arise spontaneously in immune-competent animals, in which we hypothesized that the immune tumor microenvironment also plays a role. The aims of this study were to determine the quantity and prognostic value of forkhead box protein P3-positive peritumoral and intratumoral regulatory T cells in feline invasive mammary carcinomas, and to identify an immune-suppressed subgroup of triple-negative basal-like feline invasive mammary carcinomas. One hundred and eighty female cats with feline invasive mammary carcinomas, treated by surgery only, with 2-year follow-up post-mastectomy, were included in this study. Forkhead box protein P3, estrogen receptor, progesterone receptor, Ki-67, epidermal growth factor receptor type 2, and cytokeratin 14 expression were assessed by automated immunohistochemistry. Peritumoral regulatory T cells were over 300 times more abundant than intratumoral regulatory T cells in feline invasive mammary carcinomas. Peritumoral and intratumoral regulatory T cells were associated with shorter disease-free interval and overall survival in both triple-negative (ER-, PR-, HER2-, N = 123 out of 180) and luminal (ER+ and/or PR+, N = 57) feline invasive mammary carcinomas. In feline triple-negative basal-like (CK14+) mammary carcinomas, a regulatory T-cell-enriched subgroup was associated with significantly poorer disease-free interval, overall survival, and cancer-specific survival than regulatory T-cell-poor triple-negative basal-like feline invasive mammary carcinomas. High regulatory T-cell numbers had strong and negative prognostic value in feline invasive mammary carcinomas, especially in the triple-negative basal-like subgroup, which might contain a "basal-like immune-suppressed" subtype, as described in triple-negative breast cancer. Cats with feline invasive mammary carcinomas may thus be interesting spontaneous animal models to investigate new strategies of cancer immunotherapy in an immune-suppressed tumor microenvironment.
Keywords: Basal-like breast cancer; feline mammary carcinoma; forkhead box protein P3; immune tumor microenvironment; regulatory T cells.
Similar articles
-
Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.BMC Cancer. 2019 Dec 30;19(1):1267. doi: 10.1186/s12885-019-6483-6. BMC Cancer. 2019. PMID: 31888566 Free PMC article.
-
Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.BMC Vet Res. 2019 Jan 10;15(1):25. doi: 10.1186/s12917-018-1772-x. BMC Vet Res. 2019. PMID: 30630524 Free PMC article.
-
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.Tumour Biol. 2016 Mar;37(3):4053-64. doi: 10.1007/s13277-015-4251-z. Epub 2015 Oct 20. Tumour Biol. 2016. PMID: 26486327
-
Potential prognostic tumor biomarkers in triple-negative breast carcinoma.Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Oct 18;44(5):666-72. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23073572 Review.
-
Triple-negative breast cancer: current state of the art.Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review.
Cited by
-
Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.Vet Sci. 2025 Feb 19;12(2):189. doi: 10.3390/vetsci12020189. Vet Sci. 2025. PMID: 40005948 Free PMC article. Review.
-
Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.Animals (Basel). 2023 Feb 28;13(5):878. doi: 10.3390/ani13050878. Animals (Basel). 2023. PMID: 36899736 Free PMC article.
-
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review.Breast Cancer (Dove Med Press). 2025 Mar 17;17:265-274. doi: 10.2147/BCTT.S516542. eCollection 2025. Breast Cancer (Dove Med Press). 2025. PMID: 40124876 Free PMC article. Review.
-
One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.Vet Comp Oncol. 2021 Mar;19(1):140-151. doi: 10.1111/vco.12655. Epub 2020 Sep 28. Vet Comp Oncol. 2021. PMID: 32954630 Free PMC article.
-
Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.Front Vet Sci. 2021 Jan 22;7:622019. doi: 10.3389/fvets.2020.622019. eCollection 2020. Front Vet Sci. 2021. PMID: 33553286 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous